5.43

0.18% -0.01

After Hours: 5.25 -0.18 -3.31%

Enveric Biosciences Inc (ENVB)

Overview News Price History Financials Discussions Forecast Stock Split Dividend History

Enveric Biosciences Inc stock is traded at $5.43, with a volume of 287.48K. It is down -0.18% in the last 24 hours and down -9.20% over the past month. Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Previous Close:

$5.44

Open:

$6.23

24h Volume:

287.48K

Relative Volume:

0.45

Market Cap:

$3.24M

Revenue:

Net Income/Loss:

$-15.08M

P/E Ratio:

-0.8458

EPS:

-6.42

Net Cash Flow:

$-11.56M

1W Performance:

-20.03%

1M Performance:

-9.20%

6M Performance:

-63.51%

1Y Performance:

-91.51%

1-Day Range:

$5.35

$6.23

1-Week Range:

$5.05

$13.25

52-Week Range:

$4.88

$96.30

Enveric Biosciences Inc Stock (ENVB) Company Profile

Name

Enveric Biosciences Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

239-302-1707

Address

245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

ENVB's Discussions on Twitter

Compare ENVB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ENVB Enveric Biosciences Inc	5.43	3.25M	0	-15.08M	-11.56M	-6.42
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Enveric Biosciences Inc Stock (ENVB) Latest News

Dec 12, 2025

Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds - pharmiweb.com

Dec 12, 2025

Enveric Biosciences raises $3.1 million through warrant exercise - Investing.com

Dec 12, 2025

Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds - BioSpace

Dec 12, 2025

Dec 11, 2025

Enveric Biosciences (ENVB) Modifies Warrant Terms to Raise Funds - GuruFocus

Dec 11, 2025

Enveric Biosciences secures $3.1 million through warrant exercise By Investing.com - Investing.com Canada

Dec 11, 2025

Enveric Biosciences secures $3.1 million through warrant exercise - Investing.com

Dec 11, 2025

Enveric Biosciences shareholders approve stock issuance and share increase proposals - Investing.com

Dec 11, 2025

Enveric Biosciences Approves Key Stockholder Proposals - TipRanks

Dec 11, 2025

Enveric Biosciences skyrockets on patent allowance for psychedelic-inspired molecules - Mugglehead Magazine

Dec 11, 2025

Enveric Biosciences approves key stockholder proposals - MSN

Dec 11, 2025

Dec 10, 2025